Join the Onychomycosis - Toenail group to help and get support from people like you.
Onychomycosis - Toenail News
Related terms: Fungal Infection, Toenail, Infection, Fungal, Toenail
Individuals With BAP1 Have High Rate of Nail Abnormalities
MONDAY, May 20, 2024 – Individuals with BRCA1-associated protein (BAP1) have a high rate of nail abnormalities consistent with onychopapillomas, according to a study published online May 17 in JAMA...
FDA Approves Ortho Dermatologics' Labeling for Jublia (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old
LAVAL, Quebec, April 29, 2020 /PRNewswire/ – Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care...
FDA Medwatch Alert: Nizoral (ketoconazole) Oral Tablets: Drug Safety Communication - Prescribing for Unapproved Uses including Skin and Nail Infections Continues; Linked to Patient Death
ISSUE: FDA is warning health care professionals to avoid prescribing the antifungal medicine ketoconazole oral tablets to treat skin and nail fungal infections. Use of this medication carries the...
FDA Approves Kerydin (tavaborole) Topical Solution for Onychomycosis of the Toenails
PALO ALTO, Calif. July 8, 2014--(BUSINESS WIRE)-- Anacor Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Kerydin...
Valeant Pharmaceuticals Announces FDA Approval Of Jublia for the Treatment of Onychomycosis
LAVAL, Quebec, June 9, 2014 /PRNewswire/ – Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received...
Ask a question
To post your own question to this support group, sign in or create an account.